Purchase Order 75N92020P00139
- Not listed
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to CD Biosciences Inc., doing business as Creative Biomart, for COVID-19 next-generation sequencing services. The $24,450.00 contract has a period of performance through September 20, 2022. CD Biosciences Inc. is a research product supplier and contract research organization that provides a wide range of specialized molecular biology services to federal agencies,...
- This federal contract award for $22,360.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for gynotyping and sequencing services, with a completion date of September 17, 2024. CD Biosciences Inc., doing business as Creative Biomart, specializes in genomic sequencing, bioinformatics analysis, and other laboratory services to support research...
- The U.S. government has awarded a $22,890.00 Firm Fixed Price purchase order contract to CD Biosciences Inc., doing business as Creative Biomart, a small business provider of biotechnology services. The contract, which is a set-aside for small businesses, is for the "SEQUENCING CMBS INSECT PROGRAM" and has an ultimate completion date of July 30, 2024. CD Biosciences Inc. is a small business that specializes in genomic sequencing, bioinformatics analysis, and other molecular biology...
- This federal contract award is for ILLUMINA NOVASEQ SEQUENCING (PE150) services provided by CD Biosciences Inc., a small business research product supplier and contract research organization. The $4,230 firm fixed price purchase order was awarded on September 4, 2020 by a civilian agency, the Pacific West Area of an unnamed federal agency, with a completion date of September 30, 2021. No set-aside was used for this award. CD Biosciences Inc. operates under multiple divisions including Creative...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to CD Biosciences Inc., doing business as Creative Biomart, for metagenomic shotgun sequencing services. The contract has a potential value of $20,000.00 and a completion date of March 20, 2025. CD Biosciences Inc. is a research product supplier and contract research organization that has previously provided a...
- This is a $14,790 firm fixed-price purchase order awarded to CD Biosciences Inc., doing business as Creative Biomart, a small business research product supplier and contract research organization. The contract, which has no set-aside designation, is for RNA sequencing services to support the research efforts of a U.S. civilian federal agency, the Midwest Area of the agency identified. CD Biosciences Inc. is an experienced provider of specialized scientific services to federal agencies, with a...
- This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Government Scientific Source Inc. for single-cell RNA sequencing kits. The $37,366.64 firm-fixed-price delivery order contract is awarded under the Multiple Award Schedule (MAS) contract vehicle and has an ultimate completion date of August 18, 2025. The contract supports the NHLBI Young Lab's analysis of expression levels of various factors in...
- CD Biosciences Inc., doing business as Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen Division, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide creative diagnostics glycoproteins and nucleoproteins. The contract has a period of performance from September 22, 2023 through December 29, 2023, with all work to be conducted by the prime contractor in East Yaphank, New...
- This is a federal contract award by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Government Scientific Source Inc., a for-profit organization based in Reston, Virginia, to provide 10X Genomics single cell sequencing library preparation reagents. The contract has a firm fixed price of $43,426.50 and a period of performance that runs through October 5, 2025. The contract was awarded...
- This firm-fixed-price purchase order contract was awarded to CDI Laboratories Inc., a small disadvantaged business, to provide its proprietary HUPROT V4.0 ARRAY protein microarray product and related antibody profiling and analysis services to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $121,379.50 contract supports biomedical research efforts, particularly in the areas of infectious diseases, heart/lung disorders, aging, and...
This federal contract award, valued at $15,575.00, was issued by the National Heart Lung and Blood Institute (NHLBI) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for the provision of RNA sequencing services for 115 samples, with a completion date of May 22, 2020. The contract is a firm fixed-price purchase order, and is designated as a total small business set-aside. CD Biosciences Inc. operates under multiple divisions, including Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen, and is registered in the System for Award Management (SAM) through July 2025. The company has been awarded numerous federal contracts from civilian agencies, including the National Institute of Allergy and Infectious Diseases (NIAID), Centers for Disease Control and Prevention (CDC), U.S. Department of Agriculture (USDA), Veterans Affairs (VA), and Food and Drug Administration (FDA), primarily for specialized scientific services such as genomic sequencing, bioinformatics analysis, and molecular biology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($7k) | 4/18/25 | |
| Not listed | Not listed | $22.2k | 5/21/20 |